Fig. 3From: Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinomaLYRM4 promoter methylation profile of LIHC patient subgroups based on sample types (a), race (b), tumour grade (c), and nodal metastasis status (d) (UALCAN database). Data are shown as mean ± SE. *, p < 0.05; **, p < 0.01; ***, p < 0.001. The asterisk indicates a significant difference between the two sets of dataBack to article page